Format

Send to

Choose Destination
Trials. 2015 Oct 7;16:445. doi: 10.1186/s13063-015-0966-9.

Evaluating the use of fibrin glue for sealing low-output enterocutaneous fistulas: study protocol for a randomized controlled trial.

Author information

1
Department of Surgery, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China. xiuwenwoo@gmail.com.
2
Department of Surgery, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China. JiananR@gmail.com.
3
Department of Surgery, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China. wgfwang@gmail.com.
4
Department of General Surgery, The 1st Affiliated Hospital of Gannan Medical College, Ganzhou, China. surgeonwjz@163.com.
5
Department of General Surgery, The Affiliated Hospital of Neimenggu Medical University, Huhehaote, China. winer_77@163.com.
6
Department of General Surgery, Chinese Medical University Aviation Hospital, Beijing, China. fanyp900164@sina.com.
7
Department of General Surgery, The 309th Hospital of The Chinese People's Liberation Army, Beijing, China. liyuanxin1966@163.com.
8
Department of Surgery, The Second Hospital of Jilin University, Changchun, China. gmail1973@163.com.
9
Department of General Surgery, Affiliated Hospital of Medical College Qingdao University, Qingdao, China. shougencao@gmail.com.
10
Department of General Surgery, Henan Province People's Hospital, Zhengzhou, China. xiaofei81920@163.com.
11
Department of Gastrointestinal Surgery, Xuzhou Central Hospital, Xuzhou, China. surgeonzhao@163.com.
12
Department of Surgery, VA Medical Center, 830 Chalkstone Avenue, Providence, USA. minyao99@hotmail.com.
13
Department of Surgery, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China. jieshou_li@163.com.

Abstract

BACKGROUND:

The management of an enterocutaneous fistula poses a significant challenge to surgeons and is often associated with a costly hospital stay and long-term discomfort. The use of fibrin glue in the fistula tract has been shown to promote closure of low output enterocutaneous fistulas. Our previous nonrandomized study demonstrated that autologous platelet-rich fibrin glue treatment significantly decreased time to fistula closure and promoted closure rates. However, there are several limitations in the study, which may lead to bias in our conclusion. Thus, a multicenter, randomized, controlled clinical trial is required.

METHODS/DESIGN:

The study is designed as a randomized, open-label, three-arm, multicenter study in nine Chinese academic hospitals for evaluating the efficacy and safety of fibrin glue for sealing low-output fistulas. An established number of 171 fistula patients will undergo prospective random assignment to autologous fibrin glue, commercial porcine fibrin sealants or drainage cessation (1:1:1). The primary endpoint is fistula closure time (defined as the interval between the day of enrollment and day of fistula closure) during the 14-day treatment period.

DISCUSSION:

To our knowledge, this is the first study to evaluate the safety and efficacy of both autologous and commercial fibrin glue sealing for patients with low-output volume fistulas.

TRIAL REGISTRATION:

NCT01828892 . Registration date: April 2013.

PMID:
26445823
PMCID:
PMC4597766
DOI:
10.1186/s13063-015-0966-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center